The Austrian Centre of Industrial Biotechnology (acib) has 200+ employees and 30+ years of experience. acib provides exciting R&D project ideas at the acib online research marketplace: acib.at/offers/
acib is a reliable and innovative partner in dozens of (inter)national funding projects from FP7 to HorizonEurope, EIC, MSCA-ITN, MSCA-RISE, FFG, FWF etc., but also available for contract research. acib acts as a hub of industrial biotechnology and has a large network of partners.
We find new ways to improve medical care worldwide with our products and services. Clean-room-production and robot-assisted precision for your challanges in modern medical technology.
Microsynth Austria is an Austrian subsidiary of Microsynth AG and is located at the Biotechnology Center in Vienna. The parent company has it's headquarter in Balgach, Switzerland, and operates further subsidiaries in Germany (Microsynth Seqlab) and France (Microsynth France). Altogether Microsynth employs a staff of more than 100 people.
Eyecre.at GmbH, a company known for its specialized production of artificial eyes used in ophthalmology and wet labs, is expanding its field of activity to encompass general anatomical 3D printing. Leveraging their expertise in creating hyper-realistic models for medical training and surgical planning, eyecre.at GmbH aims to provide a broader range of anatomical models. With a commitment to maintaining the same high standards of accuracy and quality, their goal is to provide healthcare professionals with the most realistic and detailed training tools and patient care solutions in the market.
LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Labour and Economy and the City of Vienna, it contributes to the advancement of life sciences in Vienna. LISAvienna supports innovative biotech, pharmaceutical, medical device and digital health companies in Vienna that develop and market new products, services and processes. The platform links these companies with development partners and key customers. As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.
ffffff
We are a healthcare consulting firm based in Vienna, with a strategic focus on Austria, Germany and Sitzerland. As experts in the fields of pharmaceuticals and medical technology, we support companies at all stages of their developement with solutions tailored to the specific needs of our clients: General project management/ Support in the implementation of clinical trials/ Product approval & price negotiations/ Market launch & commercialization / Inventory management & logistics
BPHS is an Austrian firm with extensive experience spanning 25+years in the healthcare, pharma and medtech industries. Comprised of a diverse team of experienced experts and young professionals, BPHS provides comprehensive consulting services for IT solutions, quality management and logistics/distribution solutions.Over the years, the company has fostered valuable connections within the industries, solidifying its reputation as a reliable and trustworthy teamplayer with a "can-do" mentality.
We develop, manufacture and sell innovative solutions for blood banks and transfusion medicine. As a team of motivated and talented individuals who put the needs of our customers first we are dedicated to simplifying the daily work of doctors, technical and nursing staff whilst increasing safety in clinical practice.
A hughe network about more then 600 global manufacturers, long time experiences in the laboratory market support researchers and lab product users professionally in there daily work.
A great and fair partnership helps to live always a great win win partnership together with our clients.
The European Institute of Innovation & Technology (EIT) is an independent institution of the European Union, founded in 2008 to promote innovation and entrepreneurship across Europe. Since 2014, the network initiative has also been active in the field of health in Europe. EIT Health is currently working with around 130 members in a "public-private partnership" to find solutions to the major healthcare challenges of our time. Leading companies, public institutions as well as renowned universities and research institutions are working together with start-ups and SMEs in innovative programmes and projects to develop new products and services that promote a sustainable health economy in Europe. The aim of EIT Health is to close the innovation gap in the life science sector.
EIT Health Austria is one of a total of eight EIT Health centres in Europe and currently supports 15 members from industry, research and education in Austria, including Boehringer Ingelheim, Med Uni Graz, the Ludwig Boltzmann Gesellschaft, as well as start-ups and SMEs in the development of groundbreaking innovations in healthcare. With the "HealthGateway.Austria" project, EIT Health Austria also operates an innovation laboratory in Vienna funded by the FFG, which increasingly integrates Austrian companies and organisations in the life science sector into the activities of EIT Health.
Altus Biolabs is an analytical laboratory specialized in the analysis of cannabinoids in various cannabis products as well as the development of analytical assays for the detection of plant pathogens. Our goal is to ensure the quality and safety of cannabis products on the market and to help their producers streamline their processes
Core areas of expertise are design, development and production of real-time PCR-based tests for the detection of various pathogens such as bacteria, viruses, fungi and parasites, for applications in human and veterinary medicine.
RIANA Therapeutics' approach to drug discovery is based on its proprietary platform technology for discovering compounds that target cancer-promoting protein-protein interactions (PPIs). Using this novel approach, RIANA is searching for inhibitors that block the formation of specific oncogenic PPIs. RIANA is currently working to develop new compounds that specifically target acute myeloid leukemia (AML) as well as other blood cancers and certain types of solid tumors.
CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies in developing cutting-edge biotech projects
IT Support for Life Science. Cybersecurity, Computational Biology )Bioinformatics), "Big Pharma" digital Compliance
In 2019, the healthcare policy and communication expert Michael Eipeldauer founded the management and public affairs consulting company Eipeldauer-Consulting e.U.
CALYXHA develops novel small-molecule anti-inflammatory drugs
MAG – Molecular Architecture Group – brings together scientists with decades-long experience in NMR applications for drug design
Karyon Biopharma Consulting e.U. supports clients during non-clinical drug development.
Services encompass:
• Design of product-tailored non-clinical development plans for medicinal products to enable CTA/IND (small molecules, biologics, ATMPs (cell- and vector-based), vaccines)
• Support in CRO selection and placement of studies at CROs (request for proposals for complex non-clinical programs, CRO comparisons up to placement and elaboration of detailed study plans)
• Involvement in study designs for non-GLP and GLP studies, monitoring and study report reviews, including data interpretation
• Support for regulatory questions: early regulatory strategy, preparation and conduct of regulatory interactions with regulatory Authorities, including coordination and moderation of Scientific Advice Meetings (national Authorities / EMA / FDA)
• Scientific writing of a broad range of (regulatory) documents, including non-clinical parts of Briefing Documents for Scientific Advice Meetings, IBs, non-clinical summaries and overviews of CTDs / INDs, non-clinical ATMP certification dossiers
• Preparation of different types of toxicological risk assessments / expert statements
• Preparation of biological evaluation reports (BERs) for substance-based medical devices
For further details, please contact me at a.guenzl@karyon-consulting.com